{"title": "Active Studies", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2013-01-01", "cleaned_text": "Active Studies - MF-59 and ASO3-adjuvanted H5N8 influenza vaccines in healthy adults - Meningitis vaccine in pregnant women (domestic and international) - Tdap vaccine in pregnant women in Mali - Pharmacokinetic study of vancomycin in critically ill infants and children - Safety and immunogenicity of dmLT by different routes in Bangladesh - Mupirocin in elimination of S. aureus colonization in neonates - Malaria vaccine trials - Phase I dose escalation study of recombinant circumsporozoite protein (rCSP) antigen in healthy, malaria-na\u00efve, adults (domestic) - PfSPZ challenge study to assess safety, tolerability, immunogenicity, and efficacy of PfSPZ-CVac in Malian adults - - Phase I Challenge Study to Evaluate Safety, Immunogenicity, and Efficacy of a Malaria Vaccine (rCSP Adjuvanted with GLA-SE), in Healthy Adults* - Phase II Trial to Evaluate the Safety and Immunogenicity of MENVEO\u00ae in Pregnant Women - Lab Assays for Phase 1 Study in Healthy Adults to Determine the Safety and Immunogenicity of an Attenuated Recombinant dmLT from ETEC Vaccine - Phase I Study to Evaluate the Safety and Immunogenicity of dmLT from ETEC by Oral, Sublingual, or Intradermal Vaccination in Adults in an Endemic Area - Establishment of Central Facilities to Analyze Samples for Circulating Cytokines and Activation and/or Increase in Subpopulations of Natural Immune Cells, and T and B Cells - Phase II Trial to Evaluate the Safety, Immunogenicity and Effect on Infant Immune Responses of a Single Dose of Tdap in Pregnant Women in Africa - Safety, Tolerability, Immunogenicity and Protective Efficacy against Naturally-Transmitted Malaria of PfSPZ Challenge Administered by Direct Venous Inoculation under PfSPZ-CVac in Malian Adults* - Phase I Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of A/H5N8 Vaccine Administered at Different Dosages With or Without AS03 or MF59 Adjuvants - Population PK Study to Evaluate the Dose Needed to Achieve AUC24/MIC >/ 400 in PICU Patients on Vancomycin - Sub-study to Evaluate the Anti-Hemagglutinin Antibody Responses by Protein Microarrray in Subjects Who Received an A/H5N1 vaccine With or Without AS03 and MF59 Adjuvants - Phase 4 Trial to Evaluate the Efficacy of an Injectable Free Delamanid Containing Regimen for the Treatment of MDR TB - Phase II Study in Healthy Adults to Assess the Sequential or Simultaneous Intramuscular Administration of an AS03-adjuvanted A/H7N9 Inactivated Influenza Vaccine with Seasonal Influenza Vaccine - Phase II Study in Healthy Adults to Assess the Safety, Reactogenicity and Immunogenicity of A/H7N9 Inactivated Influenza Vaccine Administered IM With or Without AS03 Adjuvant - Phase II Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Dose of 2017 A/H7N9 Inactivated Influenza Vaccine (IIV) Administered IM zWith or in 2013 A/H7N9 IIV Primed or A/H7 IIV Na\u00efve Subjects - Phase II Trial to Evaluate the Effects of a Single Dose of Tdap in Pregnant Women in Africa - A Sub-study to Evaluate Epitope Mapping of Antibodies Elicited by Controlled Human Malaria Infection, Vaccination, and Natural Infection with Plasmodium falciparum Malaria in studies with * above. "}